Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe 7mg tablet is the second rung of the Wegovy tablet dose ladder, reached after at least a month at 1.5mg. Most side effects from oral semaglutide are gastrointestinal, tend to peak around dose changes, and ease for the majority of people within a couple of weeks. These are prescription-only medicines; a prescriber assesses your suitability and walks through your risk profile before any dose is issued. The NHS semaglutide medicines page gives a plain-language overview of what to expect across the treatment. What follows covers the 7mg step specifically, including the signs that need prompt medical attention.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Oral semaglutide slows the rate at which the stomach empties and acts on appetite centres in the brain via GLP-1 receptors. Both effects are amplified as the dose rises, which is why the 4mg and 7mg steps often bring a fresh wave of GI symptoms even in people who sailed through 1.5mg.
The most frequently reported effects at this stage are nausea, diarrhoea, constipation, burping and acid reflux. Fatigue and headache appear less often but are documented. In the OASIS 4 trial, around 74% of participants on oral semaglutide reported GI side effects at some point during treatment, compared with 42% on placebo — though most were mild to moderate and settled with time.
A practical note: the 7mg tablet is taken first thing in the morning on an empty stomach, with a small amount of plain water, and nothing else (no coffee, no food, no other medicines) for at least 30 minutes afterwards. Skipping that window, or swallowing the tablet with a meal, reduces absorption and can actually make nausea worse because the medicine sits longer in the stomach. Our page on how semaglutide tablets work covers the taking instructions in more detail.
Symptoms tend to be sharpest in the first five to ten days after moving to 7mg, and if you want a detailed breakdown of what to expect, our guide to semaglutide tablets side effects walks through each one in turn. Eating smaller portions, sticking to low-fat foods and staying well-hydrated helps most people through that window. If nausea is a real problem at this stage, it is worth discussing anti-sickness options with your prescriber before dismissing the treatment entirely, our page on anti-sickness tablets alongside Wegovy covers the evidence there.
This is the section that matters most. Not every stomach complaint is a normal GI effect.
Severe abdominal pain (particularly if it is persistent, comes on suddenly, and radiates towards the back, with or without vomiting) is a warning sign for acute pancreatitis, a serious but infrequent complication associated with GLP-1 medicines. In January 2026 the MHRA issued a formal Drug Safety Update highlighting pancreatitis as a known risk requiring urgent assessment if those symptoms appear. Do not wait to see whether the pain passes. Call 999 or go to A&E.
Other symptoms that need same-day medical contact rather than monitoring at home include: signs of a severe allergic reaction (swelling of the face, lips or throat; difficulty breathing; a widespread rash); significant dehydration from repeated vomiting or diarrhoea, dizziness on standing, very dark urine, inability to keep fluids down; and sudden changes in vision, which in people with diabetes can indicate retinopathy changes.
If you are unsure whether a symptom is serious, NHS 111 is the right first call. You can also report any suspected side effect from a prescription medicine through the Yellow Card scheme, which feeds directly into MHRA safety monitoring. Reports from patients, not just clinicians, shape the guidance that protects future users.
For a broader look at side effects across the full oral semaglutide schedule, the oral semaglutide side effects overview covers each dose step in turn.
Often, briefly. The pattern with dose escalation is that symptoms which settled at the previous step can return, usually more mildly, when the dose goes up. By 7mg most people have already learned what helps, and if you want to understand the full range of reactions that can occur, our page answering what are the side effects of semaglutide tablets sets out the evidence clearly, smaller meals, avoiding high-fat or highly processed foods, spreading fluid intake across the day rather than drinking large amounts at once.
Some people find the 7mg step harder than the initial 1.5mg introduction, because appetite suppression is now strong enough to make it genuinely difficult to eat enough protein. Muscle loss is a real concern when calorie intake drops sharply; prioritising protein at each meal is the practical counter to that, and it is something a prescriber or dietitian can advise on specifically for your situation.
If side effects at 7mg are intolerable after two to three weeks, staying at 4mg for a further month rather than pressing on is a legitimate clinical decision. The schedule is guided by a prescriber, not by a calendar. The side effects at the 14mg step are worth reading ahead of the next increase, so the picture is not a surprise.
Our prescribers discuss exactly this kind of dose-escalation question as part of every clinical review. If you have not yet started treatment and want to understand whether oral semaglutide is right for you, start your free consultation and a GPhC-registered prescriber will review your details the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.